CaseVu
Frank Bauer, MD
Dr. Frank Bauer has served as Precipio’s Medical Director since 2018. He completed his residency and fellowship at Walter Reed Army Medical Center and was appointed as Director of Hematopathology at Walter Reed with the Armed Forces Institute of Pathology. Dr. Bauer joined the pathology staff at Saint Francis Hospital and Medical Center in 1996 as Director of Hematopathology and taught medical students at UCONN and Quinnipiac Medical Schools (1996-2018).
Jason Willis, MD
Dr. Jason Willis is a board-certified hematopathologist with over 15 years of experience in both tertiary and reference lab settings, with a specific focus in flow cytometry. Dr. Willis completed his medical school at the University of Texas Southwestern in Dallas, residency at Parkland Hospital, and fellowship at UTSW. His areas of expertise include Histologic and flow cytometric diagnosis of acute leukemias, chronic myeloid neoplasms, lymphoid malignancies, plasma cell neoplasms, and related disorders. Dr. Willis is also focused on detection of minimal residual disease by flow cytometric methods, and the integration of clinical, cytogenetic, and molecular data in the diagnostic and prognostic workup of hematolymphoid malignancies. He is a member of the International Clinical Cytometry Society, ASCP, CAP, Texas Medical Association, and Dallas County Medical Society.
Hina Naushad Qureishi, MD
Dr. Hina Qureishi joined Precipio Inc. as a hematopathologist with 18 years of experience in clinical practice and training residents and fellows at academic institutions. Dr. Qureishi was a faculty member at the University of Nebraska Medical Center in Omaha (2012-2022) and an Associate Professor of Pathology. She was the section medical director for the hematology core laboratory at UNMC, medical director of University Health Center Laboratory, director of hematology core rotation for residents and chair for the clinical competency committee for hematopathology fellows. She was the director of flow cytometry and hematology laboratories at Creighton University Medical Center in Omaha (2007-2012) and the director for M2 Hematology/Oncology course at Creighton University School of Medicine. She is a graduate of Rawalpindi Medical College and completed her anatomic and clinical pathology residency at University of Nebraska Medical Center, a surgical pathology fellowship at Washington University/Barnes-Jewish Hospital in St. Louis and hematopathology fellowship at the University of Nebraska Medical Center. Her clinical and research interests include lymphoma, leukemia and myeloma, flow cytometry, laboratory hematology and quality/workflow improvement.
Bevan Tandon, MD
Dr. Tandon is a board certified hematopathologist. He completed his medical degree at Eastern Virginia Medical School with residencies at UC Irvine and Northwestern University and a Hematopathology followship at the University of Pittsburgh School of Medicine. Dr. Tandon is a member of the Association for Molecular Pathology (AMP) and Society for Hematopathology. He has published on various hematopathology areas including AML, MDS and CLL and associated diagnostic technologies including Next Generation Sequencing (NGS) and residual disease monitoring.
Seble Chekol, MD
Dr. Sebel Chekol is a board certified hematopathologist. She completed her medical degree at the University of North Carolina at Chapel hill. She also completed a fellowship in hematopathology at the University of Pennsylvania in Philadelphia, PA. She has been published in the American Journal of Pathology, British Journal of Haematology, and Cancer Medicine. Dr. Chekol has expertise in flow cytometry, FISH, and molecular techniques to profile MPN, BCR::ABL1 mutations.
Laura Wake, MD
Dr. Laura Wake is a board certified hematopathologist. She completed her medical degree at American University of the Caribbean followed by a residency at the University of Nebraska Medical Center. She also completed a fellowship in hematopathology at the National Cancer Institute/National Institutes of Health in Bethesda, MD. Dr. Wake is also the Medical Director of flow cytometry at Johns Hopkins Hospital. She has numerous publications utilizing flow cytometry and molecular techniques studying various hematologic malignancies.